WO2008076255A3 - Canine thymic stromal lymphopoietin protein and uses thereof - Google Patents

Canine thymic stromal lymphopoietin protein and uses thereof Download PDF

Info

Publication number
WO2008076255A3
WO2008076255A3 PCT/US2007/025318 US2007025318W WO2008076255A3 WO 2008076255 A3 WO2008076255 A3 WO 2008076255A3 US 2007025318 W US2007025318 W US 2007025318W WO 2008076255 A3 WO2008076255 A3 WO 2008076255A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein
canine
canine tslp
thymic stromal
peptide fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/025318
Other languages
French (fr)
Other versions
WO2008076255A2 (en
Inventor
Jeanine D Mattson
Daniel M Gorman
Waal Malefyt Rene De
Mohamad A Morsey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA2671865A priority Critical patent/CA2671865C/en
Priority to IN3372CHN2009 priority patent/IN2009CN03372A/en
Priority to BRPI0720001-3A2A priority patent/BRPI0720001A2/en
Priority to ES07867705.1T priority patent/ES2582655T3/en
Priority to MX2009006470A priority patent/MX2009006470A/en
Priority to EP07867705.1A priority patent/EP2104683B1/en
Priority to NZ578352A priority patent/NZ578352A/en
Priority to AU2007334531A priority patent/AU2007334531B2/en
Priority to KR1020097014362A priority patent/KR101525631B1/en
Application filed by Individual filed Critical Individual
Priority to CN2007800512690A priority patent/CN101631800B/en
Priority to JP2009541349A priority patent/JP2010512744A/en
Publication of WO2008076255A2 publication Critical patent/WO2008076255A2/en
Publication of WO2008076255A3 publication Critical patent/WO2008076255A3/en
Priority to IL199170A priority patent/IL199170A/en
Priority to ZA2009/04152A priority patent/ZA200904152B/en
Anticipated expiration legal-status Critical
Priority to IL215507A priority patent/IL215507A0/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/43—Sweetening agents, e.g. thaumatin, monellin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5418—IL-7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
    • C07K16/464—Igs containing CDR-residues from one specie grafted between FR-residues from another
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5418—IL-7
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/20—Dermatological disorders
    • G01N2800/202—Dermatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Botany (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention discloses a canine TSLP protein and a nucleic acid that encodes that protein. Peptide fragments of the protein that comprise specific epitopes of the canine TSLP protein are also disclosed. The canine TSLP protein and related peptide fragments may be used as an antigen for immunological assays, as well as for vaccines that induce anti-TSLP antibodies. The present invention further discloses methods of making and using the canine TSLP gene, the canine TSLP protein, and the related peptide fragments.
PCT/US2007/025318 2006-12-14 2007-12-11 Canine thymic stromal lymphopoietin protein and uses thereof Ceased WO2008076255A2 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
KR1020097014362A KR101525631B1 (en) 2006-12-14 2007-12-11 Canine thymic stromal lymphopoietin protein and uses thereof
BRPI0720001-3A2A BRPI0720001A2 (en) 2006-12-14 2007-12-11 CANINE THYMIC STROMAL LINFOPOIETIN PROTEIN AND USES
CN2007800512690A CN101631800B (en) 2006-12-14 2007-12-11 Canine thymus stromal lymphopoietin protein and its application
MX2009006470A MX2009006470A (en) 2006-12-14 2007-12-11 Canine thymic stromal lymphopoietin protein and uses thereof.
EP07867705.1A EP2104683B1 (en) 2006-12-14 2007-12-11 Canine thymic stromal lymphopoietin protein and uses thereof
NZ578352A NZ578352A (en) 2006-12-14 2007-12-11 Canine thymic stromal lymphopoietin protein and uses thereof
AU2007334531A AU2007334531B2 (en) 2006-12-14 2007-12-11 Canine thymic stromal lymphopoietin protein and uses thereof
CA2671865A CA2671865C (en) 2006-12-14 2007-12-11 Canine thymic stromal lymphopoietin protein and uses thereof
ES07867705.1T ES2582655T3 (en) 2006-12-14 2007-12-11 Canine thymic stromal lymphopoietin protein and uses thereof
IN3372CHN2009 IN2009CN03372A (en) 2006-12-14 2007-12-11
JP2009541349A JP2010512744A (en) 2006-12-14 2007-12-11 Canine thymic stromal lymphopoietin protein and uses thereof
IL199170A IL199170A (en) 2006-12-14 2009-06-04 Canine thymic stromal lymphopoietin protein and uses thereof
ZA2009/04152A ZA200904152B (en) 2006-12-14 2009-06-12 Canine thymic stromal lymphopoietin protein and uses thereof
IL215507A IL215507A0 (en) 2006-12-14 2011-10-03 Canine thymic stromal lymphopoietin protein and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87513506P 2006-12-14 2006-12-14
US60/875,135 2006-12-14

Publications (2)

Publication Number Publication Date
WO2008076255A2 WO2008076255A2 (en) 2008-06-26
WO2008076255A3 true WO2008076255A3 (en) 2008-09-18

Family

ID=39430681

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/025318 Ceased WO2008076255A2 (en) 2006-12-14 2007-12-11 Canine thymic stromal lymphopoietin protein and uses thereof

Country Status (18)

Country Link
US (3) US7718772B2 (en)
EP (1) EP2104683B1 (en)
JP (4) JP2010512744A (en)
KR (1) KR101525631B1 (en)
CN (2) CN102584998B (en)
AU (1) AU2007334531B2 (en)
BR (1) BRPI0720001A2 (en)
CA (1) CA2671865C (en)
CO (1) CO6210756A2 (en)
ES (1) ES2582655T3 (en)
IL (2) IL199170A (en)
IN (1) IN2009CN03372A (en)
MX (1) MX2009006470A (en)
NZ (1) NZ578352A (en)
RU (2) RU2457217C2 (en)
UA (3) UA120027C2 (en)
WO (1) WO2008076255A2 (en)
ZA (1) ZA200904152B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA120027C2 (en) * 2006-12-14 2019-09-25 Шерінг-Плау Лтд. Isolated antibody against canine thymus stromal lymphopoietin (TSLP)
JP5492158B2 (en) 2011-08-24 2014-05-14 富士フイルム株式会社 Antibodies against human TSH and dog TSH
WO2013119419A1 (en) 2012-02-08 2013-08-15 North Carolina State University Treatment of allergic diseases with recombinant antibodies
AR090915A1 (en) 2012-05-04 2014-12-17 Intervet Int Bv PROTEIN OF FUSION OF PROTEIN LINFOPOYETINA ESTROMAL TIMICA CANINA WITH THE REGION FC OF IGG
US20160052985A1 (en) * 2013-04-04 2016-02-25 Ieo - Istituto Europeo Di Oncologia Srl Thymic stromal lymphopoietin fragments and uses thereof
UA119328C2 (en) * 2013-08-09 2019-06-10 Астеллас Фарма Інк. Novel anti-human tslp receptor antibody
CN106029697B (en) 2013-12-20 2021-06-04 英特维特国际股份有限公司 Canine antibodies with modified CH2-CH3 sequences
WO2015118124A1 (en) * 2014-02-06 2015-08-13 Vib Vzw Thymic stromal lymphopoietin receptor antagonist
CA2980087A1 (en) 2015-04-02 2016-10-06 Intervet International B.V. Antibodies to canine interleukin-4 receptor alpha
EA038332B1 (en) 2015-09-09 2021-08-10 Новартис Аг Thymic stromal lymphopoietin (tslp)-binding molecules and methods of using the molecules
HRP20210650T1 (en) 2015-09-09 2021-05-28 Novartis Ag Thymic stromal lymphopoietin (tslp)-binding antibodies and methods of using the antibodies
CA3005696A1 (en) 2015-12-18 2017-06-22 Intervet International B.V. Caninized human antibodies to human and canine il-4r alpha
US11091556B2 (en) 2015-12-18 2021-08-17 Intervet Inc. Caninized human antibodies to human IL-4R alpha
WO2018089335A1 (en) 2016-11-09 2018-05-17 North Carolina State University Treatment of allergic diseases with chimeric protein
US12060437B2 (en) 2018-03-23 2024-08-13 North Carolina State University Methods and compositions for antibody to high affinity receptor for IgE
CN115028722B (en) * 2021-03-05 2024-09-03 拜西欧斯（北京）生物技术有限公司 Anti-TSLP antibody and its preparation method and use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000029581A1 (en) * 1998-11-13 2000-05-25 Immunex Corporation Human tslp dna and polypeptides

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
ZA887773B (en) 1987-10-26 1989-07-26 Immunex Corp Interleukin-7
US5714585A (en) 1987-10-26 1998-02-03 Sterling Winthrop, Inc. Antibodies that are immunoreactive with interleukin-7
US5413914A (en) 1993-07-07 1995-05-09 The Regents Of The University Of Colorado Yeast assay to identify inhibitors of dibasic amino acid processing endoproteases
US6844170B1 (en) 1998-03-19 2005-01-18 Human Genome Sciences, Inc. Cytokine receptor common gamma chain like
US20030099947A1 (en) 1998-09-21 2003-05-29 Bazan J. Fernando Mammalian cytokines; related reagents and methods
EP1140976A4 (en) 1998-12-30 2003-05-21 Millennium Pharm Inc Secreted proteins and uses thereof
GB9908533D0 (en) * 1999-04-14 1999-06-09 Novartis Ag Organic compounds
ES2391124T3 (en) 2000-06-28 2012-11-21 Amgen Inc. Thymic stromal lymphopoietin receptor molecules and uses thereof
US6890734B2 (en) 2000-11-10 2005-05-10 Schering Corporation Nucleic acids encoding a cytokine receptor complex
SI1651247T1 (en) * 2003-07-18 2009-02-28 Schering Corp Treatment and diagnosis of neoplasms using thymic stromal lymphopoietin
US20090156467A1 (en) * 2004-07-28 2009-06-18 Zhengbin Yao Thymic stromal lymphpoietin promoter and use therefor
SE532251C2 (en) * 2006-11-28 2009-11-24 Theravac Pharmaceuticals Ab New formulations of TSLP for the treatment of TH2-mediated inflammatory diseases by vaccination
UA120027C2 (en) 2006-12-14 2019-09-25 Шерінг-Плау Лтд. Isolated antibody against canine thymus stromal lymphopoietin (TSLP)

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000029581A1 (en) * 1998-11-13 2000-05-25 Immunex Corporation Human tslp dna and polypeptides

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE UniProt [online] 1 December 2001 (2001-12-01), "Thymic stromal lymphopoietin precursor.", XP002482348, retrieved from EBI accession no. UNIPROT:Q969D9 Database accession no. Q969D9 *
LIU Y -J: "Thymic stromal lymphopoietin: Master switch for allergic inflammation", JOURNAL OF EXPERIMENTAL MEDICINE 20060220 US, vol. 203, no. 2, 20 February 2006 (2006-02-20), pages 269 - 273, XP002482347, ISSN: 0022-1007 0022-1007 *
QUENTMEIER H ET AL: "CLONING OF HUMAN THYMIC STROMAL LYMPHOPOIETIN (TSLP) AND SIGNALING MECHANISMS LEADING TO PROLIFERATION", LEUKEMIA, MACMILLAN PRESS LTD, US, vol. 15, no. 8, 1 August 2001 (2001-08-01), pages 1286 - 1292, XP001203456, ISSN: 0887-6924 *
RECHE P A ET AL: "Human thymic stromal lymphopoietin preferentially stimulates myeloid cells", JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, vol. 167, no. 1, 1 July 2001 (2001-07-01), pages 336 - 343, XP002348557, ISSN: 0022-1767 *

Also Published As

Publication number Publication date
RU2012113162A (en) 2013-10-20
US20110033478A1 (en) 2011-02-10
CA2671865C (en) 2017-01-10
US20130183291A1 (en) 2013-07-18
US7718772B2 (en) 2010-05-18
EP2104683B1 (en) 2016-05-25
BRPI0720001A2 (en) 2013-12-24
AU2007334531B2 (en) 2012-04-12
MX2009006470A (en) 2009-06-26
UA120027C2 (en) 2019-09-25
US8791242B2 (en) 2014-07-29
CA2671865A1 (en) 2008-06-26
JP2013048637A (en) 2013-03-14
CN102584998B (en) 2017-07-04
WO2008076255A2 (en) 2008-06-26
RU2617957C2 (en) 2017-04-28
JP2012090647A (en) 2012-05-17
UA108064C2 (en) 2015-03-25
UA95329C2 (en) 2011-07-25
JP6117767B2 (en) 2017-04-19
RU2457217C2 (en) 2012-07-27
JP2010512744A (en) 2010-04-30
KR20090097921A (en) 2009-09-16
US20080152620A1 (en) 2008-06-26
ES2582655T3 (en) 2016-09-14
KR101525631B1 (en) 2015-06-04
RU2009126617A (en) 2011-01-20
JP5707380B2 (en) 2015-04-30
CO6210756A2 (en) 2010-10-20
EP2104683A2 (en) 2009-09-30
US8076456B2 (en) 2011-12-13
CN101631800A (en) 2010-01-20
CN101631800B (en) 2012-12-05
IL199170A (en) 2015-04-30
JP2015107121A (en) 2015-06-11
IN2009CN03372A (en) 2015-08-07
NZ578352A (en) 2012-05-25
CN102584998A (en) 2012-07-18
IL215507A0 (en) 2011-11-30
ZA200904152B (en) 2011-11-30
AU2007334531A1 (en) 2008-06-26

Similar Documents

Publication Publication Date Title
WO2008076255A3 (en) Canine thymic stromal lymphopoietin protein and uses thereof
JO3351B1 (en) Antigen binding proteins capable of binding thymic stromal lymphopoietin
WO2008145401A3 (en) Mutated parvovirus structural proteins as vaccines
WO2011032161A8 (en) Vaccines directed to langerhans cells
WO2008006554A8 (en) Glyco-engineered antibodies
MY162752A (en) Alpha-4-beta-7 heterodimer specific antagonist antibody
WO2008005880A3 (en) Antibodies for norovirus
WO2007106476A3 (en) Compositions and methods for enhancing the immunogenicity of antigens
WO2008098917A3 (en) Novel antibodies against igf-ir
WO2006085961A3 (en) Anti-mcp-1 antibodies, compositions, methods and uses
NZ577828A (en) Human antibodies that bind human il-12 and methods for producing
WO2008130382A3 (en) Fusion proteins comprising an anti -inflammatory cytokine and an antigen for treatment of immune disorders
WO2010121093A3 (en) Humanized antibody compositions and methods for binding lysophosphatidic acid
MX2010001237A (en) Novel antibodies.
EP1918302A3 (en) Methods for the identification and the isolation of epitope specific antibodies
WO2006125202A3 (en) Anti- mcp-1 antibodies, compositions, methods and uses
WO2011153400A3 (en) Nasal immunization
WO2007018853A3 (en) Secretion of antibodies without signal peptides from bacteria
WO2010009856A3 (en) Goodpasture antigen binding protein and its detection
WO2007117763A3 (en) Methods and compositions for targeting relt
WO2006135428A3 (en) Methods and compositions for inducing an immune response against multiple antigens
MX2009008754A (en) Novel antibodies against igf-ir.
WO2006108033A3 (en) Recombinant antigens for the detection of coxiella burnetii
WO2007127372A3 (en) Genetic adjuvants for viral vaccines
WO2006108658A3 (en) Process for the production of monoclonal antibodies using chimeric vlps

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780051269.0

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2007867705

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07867705

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2671865

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 12009501169

Country of ref document: PH

ENP Entry into the national phase

Ref document number: 2009541349

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2007334531

Country of ref document: AU

Ref document number: 3372/CHENP/2009

Country of ref document: IN

Ref document number: MX/A/2009/006470

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 09062338

Country of ref document: CO

ENP Entry into the national phase

Ref document number: 2007334531

Country of ref document: AU

Date of ref document: 20071211

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1020097014362

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 578352

Country of ref document: NZ

ENP Entry into the national phase

Ref document number: 2009126617

Country of ref document: RU

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 215507

Country of ref document: IL

ENP Entry into the national phase

Ref document number: PI0720001

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20090612